Performance analysis of Regenxbio (RGNX)
Annual Return
Over the past 3 years, RGNX has had an average annual return of -17.31%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, RGNX has had an average annual return of -22.66%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, RGNX has had an average annual return of +2.70%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Sep 17, 2015, RGNX has had an average annual return of -9.48%, underperforming the benchmark SPY, which returned +14.87% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -28.19% | +86.25% | -56.93% | -20.85% | -30.65% | -27.91% | +10.72% | -2.34% | +26.16% | +79.25% | +11.74% | -45.48% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -22.50% | -18.99% | -7.31% | +7.05% | -21.86% | +70.89% | -13.68% | -28.19% | |||||
| 2025 | +4.37% | -18.57% | +8.80% | +34.41% | -7.92% | -7.23% | +3.67% | +4.94% | +8.05% | +32.34% | +4.84% | +7.55% | +86.25% |
| 2024 | -31.37% | +41.55% | +20.83% | -27.15% | -6.51% | -18.48% | +21.81% | -14.25% | -14.15% | -18.11% | +15.49% | -22.07% | -56.93% |
| 2023 | +2.34% | -4.13% | -15.01% | +2.38% | -11.01% | +16.03% | -4.95% | -6.84% | -7.00% | -21.70% | +51.45% | -8.05% | -20.85% |
| 2022 | -19.27% | -0.72% | +26.63% | -16.36% | -24.21% | +17.40% | +27% | -5.96% | -10.40% | -10.45% | +0.98% | -5.11% | -30.65% |
| 2021 | -8.89% | -1.02% | -16.62% | +1.70% | +1.68% | +10.15% | -16.81% | -0.06% | +29.78% | -15.46% | -9.71% | +2.19% | -27.91% |
| 2020 | +6.25% | -8.11% | -19.05% | +22.97% | -5.42% | -2.21% | -10.13% | -7.79% | -9.83% | +4.50% | +21.14% | +30.20% | +10.72% |
| 2019 | +4.79% | +17.68% | +10.78% | -12.06% | -14.64% | +19.41% | -13.54% | -22.34% | +3.21% | +0.26% | +17.29% | -2.12% | -2.34% |
| 2018 | -19.40% | +6.16% | +4.92% | +25.12% | +45.12% | +32.38% | -2.02% | +0.21% | +7.17% | -11.70% | -10.14% | -29.98% | +26.16% |
| 2017 | -0.26% | -0.54% | +4.88% | +8.30% | -18.18% | +15.49% | -8.87% | +26.39% | +44.84% | -9.10% | -6.18% | +18.34% | +79.25% |
Drawdown analysis of Regenxbio (RGNX)
The maximum drawdown for the RGNX was -93.54%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The current RGNX drawdown is -87.41%.
Since Sep 17, 2015 RGNX has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 5 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -93.54% | Jul 10, 2018 | 1696 | Apr 8, 2025 | Ongoing | Ongoing | Ongoing |
| -76.16% | Sep 18, 2015 | 209 | Jul 19, 2016 | 299 | Sep 25, 2017 | 508 |
| -32.82% | Jan 3, 2018 | 22 | Feb 5, 2018 | 21 | Mar 7, 2018 | 43 |
| -27.46% | Mar 7, 2018 | 21 | Apr 6, 2018 | 6 | Apr 16, 2018 | 27 |
| -22.84% | Oct 11, 2017 | 24 | Nov 14, 2017 | 28 | Dec 26, 2017 | 52 |
| -10.62% | Apr 18, 2018 | 4 | Apr 24, 2018 | 11 | May 9, 2018 | 15 |
| -8.93% | May 15, 2018 | 4 | May 21, 2018 | 6 | May 30, 2018 | 10 |
| -7.66% | May 31, 2018 | 2 | Jun 4, 2018 | 1 | Jun 5, 2018 | 3 |
| -4.68% | Jun 8, 2018 | 4 | Jun 14, 2018 | 3 | Jun 19, 2018 | 7 |
| -4.48% | Oct 2, 2017 | 1 | Oct 3, 2017 | 3 | Oct 6, 2017 | 4 |
| -4.01% | Oct 6, 2017 | 1 | Oct 9, 2017 | 2 | Oct 11, 2017 | 3 |
| -3.90% | Dec 27, 2017 | 2 | Dec 29, 2017 | 1 | Jan 2, 2018 | 3 |
| -3.50% | Jun 26, 2018 | 3 | Jun 29, 2018 | 2 | Jul 3, 2018 | 5 |
| -1.46% | Sep 25, 2017 | 1 | Sep 26, 2017 | 1 | Sep 27, 2017 | 2 |
| -1.14% | Jun 6, 2018 | 1 | Jun 7, 2018 | 1 | Jun 8, 2018 | 2 |
| -0.52% | Jul 3, 2018 | 1 | Jul 5, 2018 | 1 | Jul 6, 2018 | 2 |
| -0.15% | Sep 27, 2017 | 1 | Sep 28, 2017 | 1 | Sep 29, 2017 | 2 |